SCHEMBL533068

SCHEMBL533068

Cc1cc(C)c(N2CCCC2)c(C)c1NC(=O)Nc1ccccc1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
NPSR1 Q6W5P4 3/20 0.46
MAPT P10636 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
NTRK1 P04629 2/20 0.46
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
LMNA P02545 3/20 0.44
GAA P10253 3/20 0.44
ATM Q13315 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CHRM2 P08172 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM3 P20309 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5567398 0.84 MAPT (0.44) ALDH1A1SMN1; SMN2MAPTL3MBTL1MEN1
SCHEMBL532826 0.83 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2NPSR1MAPTL3MBTL1
SCHEMBL533930 0.82 MAPT (0.54) ALDH1A1SMN1; SMN2NPSR1MAPTL3MBTL1
SCHEMBL532809 0.82 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2NPSR1MAPTL3MBTL1
SCHEMBL533668 0.79 HDAC7 (0.43) ALDH1A1SMN1; SMN2NPSR1MAPTL3MBTL1
SCHEMBL533436 0.78 RXFP1 (0.46) ALDH1A1MAPTL3MBTL1MEN1KMT2A
SCHEMBL534054 0.78 LMNA (0.46) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL532849 0.77 SMN1; SMN2 (0.49) ALDH1A1SMN1; SMN2MAPTL3MBTL1MEN1
SCHEMBL532902 0.77 L3MBTL1 (0.43) ALDH1A1SMN1; SMN2NPSR1MAPTL3MBTL1
SCHEMBL532829 0.77 KMT2A (0.53) ALDH1A1SMN1; SMN2NPSR1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed